John MacKenzie chats with Associate Professor Severine Navarro, Team Head of Mucosal Immunology at QIMR Berghofer Medical Research Institute, about groundbreaking trials of a new treatment for asthma sufferers. episode artwork

EPISODE · Jun 13, 2023 · 9 MIN

John MacKenzie chats with Associate Professor Severine Navarro, Team Head of Mucosal Immunology at QIMR Berghofer Medical Research Institute, about groundbreaking trials of a new treatment for asthma sufferers.

from Mornings with John Mackenzie · host Mornings with John Mackenzie

John MacKenzie chats with Associate Professor Severine Navarro, Team Head of Mucosal Immunology at QIMR Berghofer Medical Research Institute, about groundbreaking trials of a new treatment for asthma sufferers.The QIMR Berghofer Institute is appealing for donations to help fast-track clinical trials for a new anti-inflammatory protein that can now be synthesised.The protein is proving effective to treat asthma and could potentially work to treat a range of other conditions including hay fever, food allergies, and even coeliac. 

Episode metadata supplied by the publisher feed · Published Jun 13, 2023

Embed this episode

Ready to play

John MacKenzie chats with Associate Professor Severine Navarro, Team Head of Mucosal Immunology at QIMR Berghofer Medical Research Institute, about groundbreaking trials of a new treatment for asthma sufferers.

0:00 9:27

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Mornings with John Mackenzie?

This episode is 9 minutes long.

When was this Mornings with John Mackenzie episode published?

This episode was published on June 13, 2023.

Can I download this Mornings with John Mackenzie episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!